These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 20083814)

  • 1. ACP Journal Club. Psyllium increased symptom relief in patients with the irritable bowel syndrome more than bran or placebo.
    Luther J; Chey WD
    Ann Intern Med; 2010 Jan; 152(2):JC1-11. PubMed ID: 20083814
    [No Abstract]   [Full Text] [Related]  

  • 2. Bran and irritable bowel syndrome: the primary-care perspective.
    Miller V; Lea R; Agrawal A; Whorwell PJ
    Dig Liver Dis; 2006 Oct; 38(10):737-40. PubMed ID: 16880013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
    Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACP Journal Club: probiotics improve symptoms in adults with the irritable bowel syndrome.
    van Zanten SV
    Ann Intern Med; 2010 Sep; 153(6):JC3-7. PubMed ID: 20855796
    [No Abstract]   [Full Text] [Related]  

  • 5. ACP Journal Club. Rifaximin relieved global symptoms and bloating in the irritable bowel syndrome without constipation.
    Talley NJ
    Ann Intern Med; 2011 Apr; 154(8):JC4-7. PubMed ID: 21502645
    [No Abstract]   [Full Text] [Related]  

  • 6. ACP Journal Club. Review: Antispasmodics and antidepressants were each effective in the irritable bowel syndrome; bulking agents were not.
    Baicus C; Voiosu T
    Ann Intern Med; 2011 Dec; 155(12):JC6-7. PubMed ID: 22184708
    [No Abstract]   [Full Text] [Related]  

  • 7. ACP Journal Club. Review: Combinations of clinical findings had moderate sensitivity and specificity for diagnosing the irritable bowel syndrome.
    Bursey F
    Ann Intern Med; 2009 Mar; 150(6):JC3-13. PubMed ID: 19306495
    [No Abstract]   [Full Text] [Related]  

  • 8. A double-blind, placebo-controlled, randomized study to evaluate the efficacy, safety and tolerability of tegaserod in patients with irritable bowel syndrome.
    Nyhlin H; Bang C; Elsborg L; Silvennoinen J; Holme I; Rüegg P; Jones J; Wagner A
    Scand J Gastroenterol; 2004 Feb; 39(2):119-26. PubMed ID: 15000272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial.
    Cappello G; Spezzaferro M; Grossi L; Manzoli L; Marzio L
    Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled clinical trial of the effectiveness of the novel serotonin type 3 receptor antagonist ramosetron in both male and female Japanese patients with diarrhea-predominant irritable bowel syndrome.
    Matsueda K; Harasawa S; Hongo M; Hiwatashi N; Sasaki D
    Scand J Gastroenterol; 2008; 43(10):1202-11. PubMed ID: 18618371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of long-term treatment with octreotide on rectal sensitivity in patients with non-constipated irritable bowel syndrome.
    Klooker TK; Kuiken SD; Lei A; Boeckxstaens GE
    Aliment Pharmacol Ther; 2007 Aug; 26(4):605-15. PubMed ID: 17661764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R; Nikfar S; Abdollahi M
    Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nucleotide supplementation: a randomised double-blind placebo controlled trial of IntestAidIB in people with Irritable Bowel Syndrome [ISRCTN67764449].
    Dancey CP; Attree EA; Brown KF
    Nutr J; 2006 Jun; 5():16. PubMed ID: 16762076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study.
    Chapman ND; Grillage MG; Mazumder R; Atkinson SN
    Br J Clin Pract; 1990 Nov; 44(11):461-6. PubMed ID: 2177997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACP Journal Club. Amylmetacresol and 2, 4-dichlorobenzyl alcohol lozenges were better than placebo lozenges for relief of acute sore throat.
    Thomas MJ
    Ann Intern Med; 2010 Aug; 153(4):JC2-6. PubMed ID: 20713785
    [No Abstract]   [Full Text] [Related]  

  • 16. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J; Müller-Lissner S; Bytzer P; Corinaldesi R; Chang L; Viegas A; Schnekenbuehl S; Dunger-Baldauf C; Rueegg P
    Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irritable bowel syndrome: can nutrient manipulation help?
    Cabré E
    Curr Opin Clin Nutr Metab Care; 2010 Sep; 13(5):581-7. PubMed ID: 20531176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled trial of the 5-HT1A receptor antagonist AZD7371 tartrate monohydrate (robalzotan tartrate monohydrate) in patients with irritable bowel syndrome.
    Drossman DA; Danilewitz M; Naesdal J; Hwang C; Adler J; Silberg DG
    Am J Gastroenterol; 2008 Oct; 103(10):2562-9. PubMed ID: 18775020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The usual medical care for irritable bowel syndrome.
    Whitehead WE; Levy RL; Von Korff M; Feld AD; Palsson OS; Turner M; Drossman DA
    Aliment Pharmacol Ther; 2004 Dec; 20(11-12):1305-15. PubMed ID: 15606392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome.
    Lee KJ; Kim JH; Cho SW
    Aliment Pharmacol Ther; 2005 Nov; 22(10):981-8. PubMed ID: 16268973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.